← back to search

Dieter Henrik Heiland

German Cancer Society · DE
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Single-cell and spatial transcriptomics, Immune cells in cancer, and Neuroinflammation and Neurodegeneration Mechanisms.
h-index
41
citations
9,430
works
307
NIH funding
primary concept
Medicine
email

Recent publications

Programs, origins and immunomodulatory functions of myeloid cells in glioma
Nature 2025cited by 92position: middledoi
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics
Nature Cancer 2025cited by 26position: middledoi
Extracellular Vesicles Carrying Tenascin-C are Clinical Biomarkers and Improve Tumor-Derived DNA Analysis in Glioblastoma Patients
ACS Nano 2025cited by 19position: middledoi
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment
Journal of Experimental & Clinical Cancer Research 2025cited by 7position: middledoi
Dual aVß8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Tumor Immunity
Neuro-Oncology 2025cited by 6position: middledoi
Intraoperative classification of CNS lymphoma and glioblastoma by AI-based analysis of Stimulated Raman Histology (SRH)
Brain and Spine 2025cited by 6position: middledoi
Spatially resolved transcriptomics of benign and malignant peripheral nerve sheath tumors
Neuro-Oncology 2025cited by 5position: lastdoi
Gasdermin E in glioblastoma –pyroptosis resistance and tumor-promoting functions
Cell Death Discovery 2025cited by 3position: middledoi
TMIC-81. Targeting TGFβ-mediated B cell suppression enhances anti-PD-1 efficacy in glioblastoma
Neuro-Oncology 2025cited by 0position: middledoi
A prognostic neural epigenetic signature in high-grade glioma
Nature Medicine 2024cited by 103position: middledoi
Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing
Cell 2024cited by 92position: middledoi
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
Genome Medicine 2024cited by 49position: middledoi
Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue
Nature Communications 2024cited by 48position: middledoi
Cranioencephalic functional lymphoid units in glioblastoma
Nature Medicine 2024cited by 41position: middledoi
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance
Nature Communications 2024cited by 37position: middledoi
Localization of protoporphyrin IX during glioma-resection surgery via paired stimulated Raman histology and fluorescence microscopy
Nature Biomedical Engineering 2024cited by 29position: middledoi
Understanding glioblastoma at the single-cell level: Recent advances and future challenges
PLoS Biology 2024cited by 23position: lastdoi
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors
npj Precision Oncology 2024cited by 12position: middledoi
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator
Neuro-Oncology 2024cited by 11position: middledoi
Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells
Journal of Neuro-Oncology 2024cited by 6position: middledoi
An AMP‐activated protein kinase‐PGC‐1α axis mediates metabolic plasticity in glioblastoma
Clinical and Translational Medicine 2024cited by 6position: middledoi
Mapping myeloid cell function: Spatial diversity in tumor and neuronal microenvironment
Cancer Cell 2024cited by 3position: lastdoi
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma
Neuro-Oncology 2024cited by 2position: middledoi
Modulation of the Tumor Microenvironment By CCL19 in Primary CNS Lymphomas
Blood 2024cited by 1position: middledoi
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects
Journal of Clinical Investigation 2023cited by 183position: middledoi
EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma
Molecular Cell 2023cited by 62position: middledoi
Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence
Genome Medicine 2023cited by 36position: middledoi
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production
Science Advances 2023cited by 32position: middledoi
Sialic acid metabolism orchestrates transcellular connectivity and signaling in glioblastoma
Neuro-Oncology 2023cited by 20position: lastdoi
Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis
Neuro-Oncology 2023cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Oliver Schnell · Johannes Gutenberg University Mainz14 papers (2017–2025)Marco Prinz · Brain (Germany)9 papers (2017–2025)Jürgen Beck · University of Utah9 papers (2021–2025)Maria Stella Carro · University of Insubria6 papers (2017–2022)Nicolas Neidert · University of Freiburg6 papers (2021–2025) · 6 papers (2021–2025)Irina Mader · University Children’s Hospital Basel4 papers (2016–2019)Junyi Zhang · University of Freiburg4 papers (2022–2024) · 4 papers (2019–2022)Andreas Vlachos · University of Freiburg4 papers (2021–2023) · 4 papers (2017–2022) · 4 papers (2017–2022)Melanie Börries · University of Freiburg4 papers (2017–2022)Daniel Delev · 4 papers (2018–2025) · 4 papers (2017–2022)Geoffroy Andrieux · University of Freiburg4 papers (2020–2023) · 4 papers (2021–2025)Jason Miska · Northwestern University3 papers (2023–2025)Vidhya M. Ravi · University of Freiburg3 papers (2022–2023)Volker A. Coenen · Johns Hopkins Medicine3 papers (2021–2025)